CLINICAL_TRIALS
research
· 2026-04-13
Clinical Trial Update: Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers [Phase 1]
Summary
Phase 1 clinical trial evaluating CBX-12 in adults with advanced solid tumors, including metastatic disease, is currently recruiting. The study aims to assess s…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 1 | Status: RECRUITING